Ilaris Injectable is utilized for Cryopyrin-related intermittent disorder, Systemic adolescent idiopathic joint arthritis and different conditions.
Ilaris Injectable may also be utilized for purposes not recorded in this drug manage.
Ilaris Injectable contains Canakinumab as a functioning fixing.
Ilaris Injectable works by decreasing the action of interleukin-1 beta protein.
Definite data identified with Ilaris Injectable’s uses, composition, dosage, reactions and audits is recorded underneath.
Ilaris Injectable is utilized for the treatment, control, prevention and improvement of the accompanying illnesses, conditions and side effects:
Cryopyrin-related occasional disorder
Systemic juvenile idiopathic joint inflammation
Ilaris Injectable may also be utilized for purposes not recorded here.
SIDE EFFECTS :
Cold side effects
Swelling or itching at the infusion site
Mild sore throat
Ilaris Injectable may also cause symptoms not recorded here.